Unknown

Dataset Information

0

Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.


ABSTRACT: BACKGROUND:B-type natriuretic peptide (BNP), a key cardiac hormone in cardiorenal homeostasis, is produced as a 108 amino acid prohormone, proBNP1-108, which is converted to a biologically active peptide BNP1-32 and an inactive N-terminal (NT)-proBNP1-76. The widely accepted model is that the normal heart releases a proteolytically processed BNP1-32 and NT-proBNP, whereas the diseased heart secretes high amounts of unprocessed/glycosylated proBNP1-108 or inappropriately processed BNPs. In contrast, circulating proBNP1-108 has recently been identified in healthy individuals, indicating that the normal heart also secretes unprocessed proBNP1-108. However, the mechanism of proBNP1-108 secretion from the normal heart remains elusive. Our goal was to determine the molecular mechanisms underlying proBNP1-108 intracellular trafficking and secretion from the normal heart. METHODS:We expressed preproBNP in cardiomyocytes, and determined the subcellular localization and dominant intracellular and extracellular forms of BNP. RESULTS:Intracellular immunoreactive BNPs were first accumulated in the Golgi apparatus, and then distributed throughout the cytoplasm as secretory vesicles. The predominant intracellular form of BNP was nonglycosylated proBNP1-108, rather than BNP1-32. Glycosylated proBNP1-108, but not nonglycosylated proBNP1-108, was detected as the major extracellular form in the culture supernatants of preproBNP-expressing cell lines and primary human cardiomyocytes. Ablation of O-glycosylation of proBNP1-108 at T71 residue, near the convertase recognition site, reduced the extracellular proBNP1-108 and increased extracellular BNP1-32. CONCLUSIONS:Intracellular proBNP trafficking occurs through a conventional Golgi-endoplasmic reticulum pathway. Glycosylation of proBNP1-108 controls the stability and processing of extracellular proBNP1-108. Our data establish a new BNP secretion model in which the normal cardiac cells secrete glycosylated proBNP1-108.

SUBMITTER: Tonne JM 

PROVIDER: S-EPMC3634583 | biostudies-literature | 2011 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.

Tonne Jason M JM   Campbell Jarryd M JM   Cataliotti Alessandro A   Ohmine Seiga S   Thatava Tayaramma T   Sakuma Toshie T   Macheret Fima F   Huntley Brenda K BK   Burnett John C JC   Ikeda Yasuhiro Y  

Clinical chemistry 20110411 6


<h4>Background</h4>B-type natriuretic peptide (BNP), a key cardiac hormone in cardiorenal homeostasis, is produced as a 108 amino acid prohormone, proBNP1-108, which is converted to a biologically active peptide BNP1-32 and an inactive N-terminal (NT)-proBNP1-76. The widely accepted model is that the normal heart releases a proteolytically processed BNP1-32 and NT-proBNP, whereas the diseased heart secretes high amounts of unprocessed/glycosylated proBNP1-108 or inappropriately processed BNPs. I  ...[more]

Similar Datasets

| S-EPMC10487184 | biostudies-literature
| S-EPMC8071624 | biostudies-literature
| S-EPMC8880403 | biostudies-literature
| S-EPMC8140656 | biostudies-literature
| S-EPMC7077038 | biostudies-literature
| S-EPMC10478300 | biostudies-literature
| S-EPMC6133645 | biostudies-literature
| S-EPMC6140599 | biostudies-literature
| S-EPMC4303547 | biostudies-literature
| S-EPMC4568029 | biostudies-literature